ProfileGDS4132 / 1561625_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 17% 19% 20% 25% 20% 19% 16% 18% 21% 19% 19% 17% 17% 23% 25% 21% 19% 19% 22% 19% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10137.268917
GSM201543Muscle PCOS pioglitazone 12136.320519
GSM201544Muscle PCOS pioglitazone 16147.270920
GSM201545Muscle PCOS pioglitazone 20165.438925
GSM201829Muscle PCOS pioglitazone 23146.742820
GSM201830Muscle PCOS pioglitazon 25144.018219
GSM201831Muscle PCOS pioglitazone 27129.82916
GSM201832Muscle PCOS pioglitazone 3139.836218
GSM201833Muscle PCOS pioglitazone 4143.326621
GSM201834Muscle PCOS pioglitazone 8139.484919
GSM201835Muscle PCOS after pioglitazone 10231.027419
GSM201836Muscle PCOS after pioglitazone 12229.744617
GSM201837Muscle PCOS after pioglitazone 16228.2217
GSM201838Muscle PCOS after pioglitazone 20245.949123
GSM201839Muscle PCOS after pioglitazone 23252.228525
GSM201840Muscle PCOS after pioglitazone 25244.504621
GSM201841Muscle PCOS after pioglitazone 27231.247519
GSM201842Muscle PCOS after pioglitazone 3231.349819
GSM201843Muscle PCOS after pioglitazone 4251.248422
GSM201844Muscle PCOS after pioglitazone 8237.113919